Variables | Overall (n = 307) | Survivors (n = 251, 81.8%) | Non-survivors (n = 56, 18.2%) | p | mRS 1–2 (n = 156, 50.8%) | mRS 3–6 (n = 151, 49.2%) | p |
---|---|---|---|---|---|---|---|
Age (years) | 57 ± 12 | 56 ± 11 | 60 ± 13 | 0.043 | 53 ± 10 | 61 ± 12 |  < 0.001 |
Male gender (n, %) | 105 (34.3%) | 83 (33.2%) | 22 (39.3%) | 0.477 | 56 (36.1%) | 49 (32.5%) | 0.577 |
Smoking (n, %) | 50 (16.3%) | 41 (16.3%) | 9 (16.1%) | 1.000 | 27 (17.3%) | 23 (15.2%) | 0.735 |
Alcoholism (n, %) | 44 (14.3%) | 38 (15.1%) | 6 (10.7%) | 0.520 | 22 (14.1%) | 22 (14.6%) | 1.000 |
Diabetes mellitus (n, %) | 16 (5.2%) | 14 (5.6%) | 2 (3.6%) | 0.781 | 8 (5.1%) | 8 (5.3%) | 1.000 |
Hypertension (n, %) | 132 (43.0%) | 109 (43.4%) | 23 (41.1%) | 0.863 | 68 (43.6%) | 64 (42.4%) | 0.922 |
Systolic blood pressure (mmHg) | 149 (130–170) | 149 (129–169) | 145 (134–170) | 0.833 | 149 (127–168) | 149 (133–172) | 0.107 |
Diastolic blood pressure (mmHg) | 86 (77 − 96) | 86 (76–97) | 87 (80–95) | 0.328 | 85 (75–98) | 87 (78–95) | 0.334 |
Heart rate (s−1) | 78 (70–89) | 78 (70–88) | 80 (65–97) | 0.912 | 78 (69–86) | 80 (70–92) | 0.012 |
GCS | 15 (11–15) | 15 (12–15) | 7 (5–12) |  < 0.001 | 15 (14–15) | 12 (7–15) |  < 0.001 |
WFNS | 2 (1–4) | 1 (1–4) | 4 (4–5) |  < 0.001 | 1 (1–2) | 4 (1–4) |  < 0.001 |
Hunt-Hess | 2 (1–3) | 2 (1–3) | 3 (3–4) |  < 0.001 | 2 (1–2) | 3 (2–4) |  < 0.001 |
mFisher | 2 (2–3) | 2 (2–3) | 3 (2–4) |  < 0.001 | 2 (2–2) | 2 (2–4) |  < 0.001 |
IVH (n, %) | 17 (5.5%) | 10 (4.0%) | 7 (12.5%) | 0.028 | 4 (2.6%) | 13 (8.6%) | 0.039 |
Location (n, %) | Â | Â | Â | 0.025 | Â | Â | 0.246 |
 Anterior circulation | 234 (76.2%) | 194 (77.3%) | 40 (71.4%) |  | 123 (78.8%) | 111 (73.5%) |  |
 Posterior circulation | 57 (18.6%) | 48 (19.1%) | 9 (16.1%) |  | 28 (17.9%) | 29 (19.2%) |  |
 Multiple aneurysm | 16 (5.2%) | 9 (3.6%) | 7 (12.5%) |  | 5 (3.2%) | 11 (7.3%) |  |
Glucose (mmol/L) | 6.79 (5.70–8.14) | 6.40 (5.62–7.89) | 7.52 (6.92–8.92) |  < 0.001 | 6.05 (5.32–7.45) | 7.44 (6.22–8.43) | < 0.001 |
Platelet (× 109/L) | 160 ± 53 | 159 ± 49 | 166 ± 67 | 0.416 | 167 ± 48 | 154 ± 57 | 0.039 |
Cystatin C (mg/L) | 0.72 (0.65–0.82) | 0.70 (0.64–0.80) | 0.82 (0.72–0.93) |  < 0.001 | 0.69 (0.63–0.77) | 0.77 (0.68–0.88) | < 0.001 |
Delayed cerebral ischemia (n, %) | 65 (21.2%) | 34 (13.5%) | 31 (55.4%) |  < 0.001 | 8 (5.1%) | 57 (37.7%) | < 0.001 |
Pneumonia (n, %) | 146 (47.6) | 112 (44.6) | 34 (60.7) | 0.042 | 46 (29.5%) | 100 (66.2%) | < 0.001 |
Intracranial infection (n, %) | 34 (11.1) | 26 (10.4) | 8 (14.3) | 0.541 | 12 (7.7%) | 22 (14.6%) | 0.082 |
Length of ICU stay (days) | 6 (3 − 13) | 6 (3 − 15) | 6 (2 − 10) | 0.280 | 4 (3–7) | 10 (5–20) | < 0.001 |
Length of hospital stay (days) | 14 (10 − 23) | 15 (11 − 24) | 9 (5 − 12) |  < 0.001 | 13 (10–17) | 17 (10 − 29) | 0.015 |